Women’s Health Diagnostics Market Size - Forecasts to 2026
The findings reviewed by GME stated that the Global Women’s Health Diagnostics Market will expand with a CAGR value of 8.2 percent from 2021 to 2026. The growing incidences of cancers like breast cancer and ovarian cancer among women and various complications during pregnancy are expected to increase the demand for women’s health diagnostics.
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on "Global Women’s Health Diagnostics Market Forecast to 2026"https://www.globalmarketestimates.com/market-report/global-womens-health-diagnostics-market-3081
By Application (Cancer (Breast Cancer Testing, Ovarian Cancer Testing, Cervical Cancer Testing), Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Prenatal Testing), By End-User (Hospital and Diagnostics Centers, Home), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis Key Market Insights
Women’s health diagnostics refer to the diagnostics techniques used to understand the ailments affecting women while some diseases like cancer and infectious diseases affect all genders, some like breast and ovarian cancer are women-centric.
Growing instances of chromosomal imbalances in the fetus have been increasing the demand for prenatal diagnostics and fertility treatments and diagnostics are also becoming increasingly common.
The development of home testing kits and methods and other forms of diagnosis has led to the dominance of this segment.
The growing number of woman-centric initiatives to improve women’s health in countries like India are also expected to increase the demand for women’s health diagnostics in the region.
Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Quest Diagnostics, Inc., Koninklijke Philips N.V., bioMérieux SA, Hologic, Inc., Abbott, GE Healthcare, PerkinElmer, Inc., and Siemens Healthcare Private Limited, among others, are the major vendors competing in the women’s health diagnostics market.
Browse
the
Report
@ https://www.globalmarketestimates.com/market-report/global-womens-health-
diagnostics-market-3081
Application Outlook (Revenue, USD Billion, 2021-2026)
Cancer Breast Cancer Testing Cervical Cancer Testing Ovarian Cancer Testing Infectious Disease Testing
Osteoporosis Testing Pregnancy and Fertility Testing Prenatal Testing
End-UserOutlook (Revenue, USD Billion, 2021-2026)
Hospitals and Diagnostic Centers Home
Regional Outlook (Revenue, USD Billion, 2021-2026) North America
The U.S. Canada Mexico
Europe
Germany UK France Spain Italy Rest of Europe
Asia Pacific
China India Japan South Korea Australia Rest of APAC
Central & South America
Brazil Argentina Rest of CSA
Middle East & Africa
Saudi Arabia UAE Rest of MEA
Contact: Tracy Simon Email address: tracy.simon@globalmarketestimates.com Phone Number: +16026667238 Website: https://www.globalmarketestimates.com/ Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php